Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
60 studies found for:    Open Studies | "Helicobacter Infections"
Show Display Options
Rank Status Study
21 Recruiting Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: (dexlan+amox+clar+metr)+(dexlan+amox);   Drug: dexlan+clarith+amox+metro
22 Recruiting Tailored Therapy for Helicobacter Pylori in Children
Condition: Helicobacter Pylori Infection
Interventions: Drug: Tailored Group;   Drug: Standard group
23 Not yet recruiting Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection
Conditions: H Pylori Infection Eradication;   Antibiotics Therapeutic Strategies;   H Pylori Eradication
Interventions: Other: Quadruple concomitant therapy treatment;   Other: Triple therapy guided by the result of the molecular resistance test
24 Not yet recruiting Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
Conditions: Helicobacter Pylori Infection;   Family History of Stomach Cancer
Interventions: Drug: Standard triple therapy;   Drug: Bismuth quadruple therapy
25 Not yet recruiting High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: Nexium 40 mg;   Drug: amoxicillin 1.5 gr;   Drug: doxycycline 200 mg;   Drug: Nexium 20 mg;   Drug: clarythromicin 500 mg;   Drug: amoxicillin 1gr
26 Recruiting Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole
Condition: Helicobacter Pylori Infection
Interventions: Other: Food effect;   Drug: Esomeprazole;   Drug: Amoxicillin;   Drug: Clarythromycin
27 Recruiting Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: pantoprazole+bismuth+tetra+metro;   Drug: (panto+amox+clar+metr)+(panto+amox)
28 Recruiting Personalized Treatment for Refractory H Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: rabeprazole+3 antibiotics;   Drug: rabeprazole+bismuth+2 antibiotics;   Drug: rabeprazole+amox+tetr+levo
29 Recruiting Comparison of Two Rescue Therapies for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: esomeprazole+amox+levo+tetra;   Drug: esomeprazole+amox+levo
30 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
31 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
32 Not yet recruiting The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection
Conditions: Caries;   Periodontitis
Intervention: Biological: Oral hygiene with Miswak
33 Recruiting Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: Gemifloxacin-based triple therapy;   Drug: Standard triple therapy
34 Recruiting The Diagnostic Validity of the Urea Breath Test
Condition: Helicobacter Pylori Infection
Intervention: Drug: Citric acid
35 Recruiting European Registry on the Management of Helicobacter Pylori Infection
Condition: H. Pylori Infection
Intervention:
36 Recruiting Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: N-acetylcysteine + PPI-amoxicillin-clarithromycin;   Drug: PPI-amoxicillin-clarithromycin
37 Recruiting Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
Condition: Helicobacter Pylori Infection
Interventions: Drug: Pantoprazole;   Drug: Amoxicillin;   Drug: Clarithromycin;   Drug: Metronidazole;   Drug: Tetracycline;   Drug: Bismuth
38 Unknown  Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections
Condition: HELICOBACTER PYLORI INFECTIONS
Intervention:
39 Recruiting Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
Conditions: Gastric Cancer;   Helicobacter Pylori Infection
Intervention: Drug: 10-day bismuth-based quadruple therapy
40 Recruiting Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: Sequential therapy 10 days;   Drug: Sequential therapy 14 days;   Drug: Concomitant therapy 10 days;   Drug: Concomitant therapy 14 days

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years